Vyant Bio, Inc. Common Stock
VYNT
VYNT was delisted on the 12th of May, 2023.
33 hedge funds and large institutions have $3.63M invested in Vyant Bio, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
14% more funds holding
Funds holding: 29 → 33 (+4)
3% more capital invested
Capital invested by funds: $3.52M → $3.63M (+$107K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$929K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$277K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$80.9K |
| 4 |
Renaissance Technologies
New York
|
+$68.5K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
+$42.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$149K |
| 2 |
SCA
Stonebridge Capital Advisors
St Paul,
Minnesota
|
-$57K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$34K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$31K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$25.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CG
26
Cutler Group
San Francisco,
California
| $2K | +$1.05K | +3 | +43% |
|
|
ASN
27
Advisory Services Network
Atlanta,
Georgia
| $1K | – | – | – |
|
28
Barclays
London,
United Kingdom
| $1K | – | – | – |
|
|
GC
29
Globeflex Capital
San Diego,
California
| $1K | +$703 | +2 | New |
|
|
KF
30
Krilogy Financial
St. Louis,
Missouri
| $1K | +$703 | +2 | New |
|
31
Bank of America
Charlotte,
North Carolina
| $1K | +$1.41K | +4 | New |
|
|
BM
32
Bridger Management
New York
| – | -$149K | -350 | Closed |
|
|
SCA
33
Stonebridge Capital Advisors
St Paul,
Minnesota
| – | -$57K | -133 | Closed |
|
|
34
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$34K | -81 | Closed |
|
|
VKH
35
Virtu KCG Holdings
New York
| – | -$31K | -74 | Closed |
|
|
AIG
36
American International Group
New York
| – | -$7K | -15 | Closed |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| – | -$2K | -4 | Closed |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$352 | +1 | New |
|
VYNT Hedge Fund Activity: Q2 2016 in Review
33 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q2 2016, worth a combined $3.63M — up 3% from $3.52M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VYNT positions and 6 closed out — a net gain of 5 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was Perkins Capital Management, adding an estimated $929K. The largest seller was Bridger Management, exiting entirely with an estimated $149K sold.
- 33 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q2 2016, up from 29 in Q1 2016.
- Funds reported $3.63M of Vyant Bio, Inc. Common Stock stock for Q2 2016, up 3% quarter-over-quarter.
- 11 funds opened new Vyant Bio, Inc. Common Stock positions in Q2 2016 and 6 closed out, a net change of +5 holders.
- The largest Vyant Bio, Inc. Common Stock buyer in Q2 2016 was Perkins Capital Management, an estimated $929K added.
- The largest Vyant Bio, Inc. Common Stock seller in Q2 2016 was Bridger Management, an estimated $149K sold.
Based on aggregated 13F filings for Q2 2016.